FFT Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
EP
FFT Wealth Management's ARKG Position: Q3 2021 in Review
FFT Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 50 shares — an estimated $5K sold.
FFT Wealth Management first reported a position in ARKG in Q2 2021 and held it in 1 quarter. The position peaked at $5K in Q2 2021. 468 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.
- FFT Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
- FFT Wealth Management sold 50 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $5K.
- FFT Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 1 quarter.
- FFT Wealth Management's ARK Genomic Revolution ETF position peaked at $5K in Q2 2021.
- 468 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.
Based on FFT Wealth Management's 13F filing for Q3 2021, filed 12 Nov 2021.